esrdThe following symbols are used throughout these tables† CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.* Values for cells with ten or fewer patients are suppressed. “ . ” Zero values in this cell.

Adjusted rates use the 2005 ESRD cohort as reference (represented by outlined columns in tables).

Data for some early years are omitted from the printed tables; complete data are available on our website, at www.usrds.org.

Table A.1Incident counts of reported ESRD: all patientsby age, gender, race, ethnicity, & primary diagnosis

esrd

Table A.1 (continued) Incident counts of reported ESRD: all patients: U.S. only, with unknowns droppedby age, gender, race, ethnicity, & primary diagnosis

Table A.2Incident rates of reported ESRDper million population, by age, gender, race, ethnicity, & primary diagnosis

esrd

Table A.2 (continued)Incident rates of reported ESRDper million population, by age, gender, race, ethnicity, & primary diagnosis

Table A.3Incident rates of reported diabetic ESRDper million population, by age, gender, race, & ethnicity

esrd

Table A.3 (continued)Incident rates of reported diabetic ESRD: CDC diabetic populationper million population, by age, gender, race, & ethnicity

Table A.5Incident rates of reported ESRD, 2006–2008 combinedper million population, by age & primary diagnosis

esrd

Table A.7Incidence of reported ESRD, by primary diagnosis, 2004–2008 combinedby detailed primary diagnosis

Table A.7 (continued)Incidence of reported ESRD, by primary diagnosis, 2004–2008 combinedby detailed primary diagnosis

esrd

Table A.7 (continued)Incidence of reported ESRD, by primary diagnosis, 2004-2008 combinedby detailed primary diagnosis

Table A.7 (continued)Incidence of reported ESRD, by primary diagnosis, 2004-2008 combinedby detailed primary diagnosis

esrd

Table B.1Point prevalent counts of reported ESRD: all patientspatients alive on December 31 of each year, by age, gender, race, ethnicity, & primary diagnosis

Table B.1 (continued) Point prevalent counts of reported ESRD patients: U.S. only, with unknowns droppedpatients alive on December 31 of each year, by age, gender, race, ethnicity, & primary diagnosis

esrd

Table B.2Point prevalent rates of reported ESRDpatients alive on December 31 of each year, per million population, by age, gender, race, ethnicity, & primary diagnosis

Table B.2 (continued)Point prevalent rates of reported ESRDpatients alive on December 31 of each year, per million population, by age, gender, race, ethnicity, & primary diagnosis

esrd

Table B.3Point prevalent rates of reported diabetic ESRDpatients alive on December 31 of each year, per million population, by age, gender, race, & ethnicity

Table B.3 (continued)Point prevalent rates of reported diabetic ESRD: CDC diabetic populationpatients alive on December 31 of each year, per million population, by by age, gender, race, & ethnicity

esrd

Table B.7Prevalence of reported ESRD, by primary diagnosis, 2008patients alive on December 31 of each year, by detailed primary diagnosis

Table B.7 (continued) Prevalence of reported ESRD, by primary diagnosis, 2008 patients alive on December 31 of each year, by detailed primary diagnosis

esrd

Table B.7 (continued) Prevalence of reported ESRD, by primary diagnosis, 2008 patients alive on December 31 of each year, by detailed primary diagnosis

Table B.7 (continued) Prevalence of reported ESRD, by primary diagnosis, 2008 patients alive on December 31 of each year, by detailed primary diagnosis

esrd

Table C.2Percent distribution of patients, by prior & current employment statusincident patients with completed Medical Evidence forms, 2000-2002, by age, gender, race, ethnicity, & primary diagnosis

Table C.2 (continued)Percent distribution of patients, by prior & current employment statusincident patients with completed Medical Evidence forms, 2003–2005, by age, gender, race, ethnicity, & primary diagnosis

esrd

Table C.2 (continued)Percent distribution of patients, by prior or current employment statusincident patients with completed Medical Evidence forms, 2006–2008, by age, gender, race, ethnicity, & primary diagnosis

Table C.3Insurance coverage in the incident population (%)incident patients with completed Medical Evidence forms, 2000-2002, by age, gender, race, ethnicity, & primary diagnosis

esrd

Table C.3 (continued)Insurance coverage in the incident population (%)incident patients with completed Medical Evidence forms, 2003-2005, by age, gender, race, ethnicity, & primary diagnosis

Table C.3 (continued)Insurance coverage in the incident population (%)incident patients with completed Medical Evidence forms, 2006-2008, by age, gender, race, ethnicity, & primary diagnosis

esrd

Table C.4Incident patient comorbidity (%)incident patients with completed Medical Evidence forms; percent with comorbidity in each year

Table C.5Time spent on hemodialysis therapyincident patients with completed Medical Evidence forms

esrd

Table D.1Percentages & counts of reported ESRD patients: by treatment modalityincident & December 31 point prevalent patients

Table D.10Incident ESRD patients, 2008, by treatment modalityby age, gender, race, ethnicity, & primary diagnosis

esrd

Table D.11Point prevalent ESRD patients, 2008, by treatment modalityDecember 31 point prevalent patients, by age, gender, race, ethnicity, & primary diagnosis

Table D.17Counts of incident ESRD patients, by payor category: all patientsby age, gender, race, ethnicity, & primary diagnosis

esrd

Table D.17 (continued)Counts of incident ESRD patients, by payor category: all patientsby age, gender, race, ethnicity, & primary diagnosis

Table D.21Counts of point prevalent ESRD patients, by payor category: all patientsDecember 31 point prevalent patients, by age, gender, race, ethnicity, & primary diagnosis

esrd

Table D.21 (continued)Counts of point prevalent ESRD patients, by payor category: all patientsDecember 31 point prevalent patients, by age, gender, race, ethnicity, & primary diagnosis

Table E.4Percent of prevalent dialysis patients wait-listed for a kidneyby age, gender, race, ethnicity, & primary diagnosis

esrd

Table E.6Renal transplants, by donor type

Table E.9Renal transplant rates, by donor typeby age, gender, race, ethnicity, & primary diagnosis, per 100 dialysis patient years

esrd

Table E.9 (continued)Renal transplant rates, by donor typeage, gender, race, ethnicity, & primary diagnosis, per 100 dialysis patient-years

Table E.9 (continued)Renal transplant rates, by donor typeage, gender, race, ethnicity, primary diagnosis, & donor relation, per 100 dialysis patient-years

esrd

Table F.2One-year graft survival probabilities: all deceased donor transplantsby age, gender, race, ethnicity, primary diagnosis, & transplant number

Table F.6Ten-year graft survival probabilities: all deceased donor transplantsby age, gender, race, ethnicity, primary diagnosis, & transplant number

esrd

Table F.8One-year graft survival probabilities: all living donor transplantsby age, gender, race/ethnicity, primary diagnosis, & transplant number

Table F.12Ten-year graft survival probabilities: all living donor transplantsby age, gender, race/ethnicity, primary diagnosis, & transplant number

esrd

Table G.1Total admission rates: ESRD patientsper 1,000 patient years, period prevalent patients, by age, gender, race, ethnicity, & primary diagnosis

Table G.2Total admission rates: dialysis patientsper 1,000 patient years, period prevalent patients, by age, gender, race, ethnicity, & primary diagnosis

esrd

Table G.5Total admission rates: transplant patientsper 1,000 patient years, period prevalent patients, by age, gender, race, ethnicity, & primary diagnosis

Table H.1Total patient deaths: ESRD patientsperiod prevalent patients, by age, gender, race, ethnicity, primary diagnosis, & patient vintage

esrd

Table H.2Annual mortality rates: ESRD patientsper 1,000 patient years at risk, period prevalent patients, by age, gender, race, ethnicity, primary diagnosis, & patient vintage

Table H.3Total patient deaths: dialysis patientsperiod prevalent patients, by age, gender, race, ethnicity, primary diagnosis, & patient vintage

esrd

Table H.4Annual mortality rates: dialysis patientsper 1,000 patient years at risk, period prevalent patients, by age, gender, race, ethnicity, primary diagnosis, & patient vintage

Table H.10Annual mortality rates: transplant patientsper 1,000 patient years at risk, period prevalent patients, by age, gender, race, ethnicity, primary diagnosis, & patient vintage

esrd

Table I.2One-year survival probabilities: incident ESRD patientsfrom day 91 to one year + 90 days, by age, gender, race, ethnicity, & primary diagnosis

Table I.6Ten-year survival probabilities: incident ESRD patientsfrom day 91 to ten years + 90 days, by age, gender, race, ethnicity, & primary diagnosis

esrd

Table J.1Certified dialysis & transplant facilities: by Medicare certification

Table K.1Total Medicare costs ($) of reported ESRD per calendar yearall ESRD patients with at least one Medicare claim, by age, gender, race, ethnicity, & primary diagnosis

esrd

Table K.6Per person per year costs ($): dialysis patients, with unknowns dropped (model 1)period prevalent patients, as-treated model, primary payor only, by age, gender, race, ethnicity, & primary diagnosis

Table K.7Per person per year costs ($): hemodialysis patients, with unknowns dropped (model 1)period prevalent patients, as-treated model, primary payor only, by age, gender, race, ethnicity, & primary diagnosis

esrd

Table K.8Per person per year costs ($): CAPD/CCPD patients, with unknowns dropped (model 1)period prevalent patients, as-treated model, primary payor only, by age, gender, race, ethnicity, & primary diagnosis

Table K.9Per person per year costs ($): transplant patients, with unknowns dropped (model 1)period prevalent patients, as-treated model, primary payor only, by age, gender, race, ethnicity, & primary diagnosis

esrd

Table K.bMedicare payments ($) per person per year: 2008, by claim type & modality (model 1)period prevalent patients, as-treated model; Medicare primary payor only